Therefore, in case of persistent thrombocytosis without leukocytosis and negative driver mutations, BCR::ABL1 will be researched to avoid missing atypical presentation of CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.